NY-JWT/MIRUM
30.1.2015 05:01:40 CET | Business Wire | Pressemeddelelse
J. Walter Thompson Company announced today the launch of Mirum, a new global company uniting 11 digital agencies spanning 17 countries and 40 offices. Former Digitaria Chief Executive Officer Dan Khabie will take the helm as Mirum Global and North America CEO. In this role, Khabie will have oversight of Mirum’s overall growth strategy, including P&L responsibility, managing key client relationships and aligning resources to service clients globally. He will report to J. Walter Thompson Company’s Global CEO, Gustavo Martinez, and be based between the West Coast and the East Coast.
Mirum is a new company created with a pioneering spirit, built by bringing together successful regional companies that have a deep understanding of local market needs. Mirum’s principles are rooted in innovation, design, data, marketing and technology to drive business transformation in a world of constantly evolving behaviors and expectations.
“The launch of Mirum is an integral part of our strategy to continue building on J. Walter Thompson Company’s many assets and capabilities in order to drive business transformation,” stated Martinez. “Mirum is poised to deliver both the technology and creative solutions that global brands demand.”
“Dan’s natural entrepreneurial instincts and passion will foster Mirum's startup mentality as he drives growth forward across our global network,” said Stefano Zunino, Head of Digital Worldwide, J. Walter Thompson, and Chairman of Mirum.
Mirum’s capabilities are organized around Strategy & Consulting services, Creative & Content, User Experience & Platforms, Analytics & Insight and Product Development & Mobile. Additionally, Mirum has deep vertical service offerings in Digital Retail, Behavioral Media and Financial Services.
Current clients include CBRE, Cyrela, Daum Kakao, Finnair, HSBC, Magazine Luiza, Mazda, Microsoft, Nokia, Petco, Singapore Tourism Board, TD Bank, Walmart and XL, among others.
“I am extremely honored to have been given this exciting yet humbling role in leading some of the most talented thinkers and makers in the world,” said Khabie. “Over the last year we have worked hard as a leadership team to integrate all of these agencies together under one common vision and operational structure while keeping the entrepreneurial spirit in each region. We have become a borderless agency with a collaborative, passionate culture, and it has already led us to win global clients that will be announced on a later date.”
Mirum companies include Digitaria (U.S.), XM (Asia Pacific), CASA (Brazil), ActivearkJWT (Finland, Sweden, India and U.K.) and Twist Image (Canada). Lunchbox (U.S.), i-Cherry (Brazil), HeathWallace (U.K.), Quirk (South Africa and U.K.), Clarus (Mexico) and X-Prime (France) will also join Mirum.
Daiga Atvara will be Chief Design Officer; Matt Webb, Chief Technology Officer; Dave Wallace, Chief Operations Officer; Nick Read, Chief Financial Officer; Sarah Kotlova, Global Head of Agency Services; and John Baker, Chief Marketing Officer. Khabie plans on naming a Chief Creative Officer, Chief Strategy Officer and Global Head of Data & Analytics over the next six months.
Khabie has also named his global leadership team, which includes Robin Bade and Markus Hakala, Europe; Rob Stokes, MEA; Guilherme Gomide, LATAM; Nanda Ivens, APAC; Mark Goodman, NA; Alex Kavinski, Behavioral Media; and Kevin Weisberg, Digital Retail Marketing.
ABOUT MIRUM
Mirum is a new agency created with a pioneering spirit, built by bringing together successful regional companies that have a deep understanding of local market needs. Our principles are rooted in innovation, design, data, marketing and technology to drive business transformation in a world of constantly evolving behaviors and expectations. Operating in 17 countries, with 40 offices and more than 2,200 professionals, Mirum is a global agency that is a part of the J. Walter Thompson Company and WPP family. For more information visit mirumagency.com .
ABOUT THE J.WALTER THOMPSON COMPANY
J. Walter Thompson Company was founded in 1864 and has been making pioneering solutions that build enduring brands and business for more than 150 years. Today under the leadership of Global CEO Gustavo Martinez, the company has evolved to include several global networks including J. Walter Thompson Worldwide and Mirum.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150129006715/en/
Contact:
WORLDWIDE, ALL ENQUIRIES
Mirum
Jocelyn Weiss-Malas, +1
646-509-6230
press@mirumagency.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum